Universidade de Cambridge apresenta colar de IA para ajudar sobreviventes de AVC a falar

University of Cambridge Unveils AI Collar to Help Stroke Survivors Speak

The University of Cambridge has unveiled an innovative wearable technology that holds promise for stroke survivors struggling with speech production. Known as Revoice, this soft, flexible collar is designed to assist individuals suffering from dysarthria, a condition that impairs the ability to articulate words clearly. By capturing muscle vibrations from the throat and heart rate signals, Revoice reconstructs speech in real time without the need for invasive brain implants. This blend of AI and speech technology opens new avenues for communication among those affected by stroke.

How the Revoice Device Works

The Revoice collar uses ultra-sensitive sensors to detect subtle throat vibrations generated when words are silently formed, as well as heart rate signals. The effectiveness of this device hinges on two main artificial intelligence components:

Phrase Reconstruction: This AI component reconstructs fragments of words into coherent speech.
Emotional Contextualization: This feature captures emotional cues and contextual factors (like the time of day or the weather) to expand short phrases into articulate sentences.

The device operates on a lightweight language model that is energy-efficient, enabling continuous use while providing fluid-sounding speech output. Users activate phrase expansion by simply nodding twice, prompting the integrated large language model (LLM) to generate complete sentences.

Key Features and Design

The Revoice device boasts several notable characteristics:

Practicality and Comfort: Resembling a fabric necklace, Revoice is lightweight, comfortable, washable, and suitable for everyday wear without appearing as medical equipment.
Non-Invasive Alternative: By avoiding the need for invasive brain implants or slow input methods like letter-by-letter typing, Revoice focuses on restoring communication signals to the affected muscles post-stroke.
Broader Applications: Beyond stroke patients, Revoice also has the potential to support individuals dealing with Parkinson’s disease and motor neuron diseases that lead to progressive speech loss.

Feature	Description
Comfortable Design	Lightweight, resembling a fabric necklace, allowing discreet wear.
Non-Invasive	No need for brain implants; safer and more user-friendly.
Versatile Use	Designed for a range of conditions, including speech impairments from strokes and other neurological disorders.

Research and Clinical Trials

Initial trials involving five dysarthria patients and ten healthy controls demonstrated:

Low Error Rates: Participants exhibited minimal errors in word/phrase recognition.
Increased Satisfaction: A remarkable 55% increase in user satisfaction and confidence was noted.

Users were able to articulate phrases like “Let’s go to the hospital,” which Revoice would contextually expand (e.g., adding reasons like “It’s already late”). These promising results were published in the journal Nature Communications in 2026 (DOI: 10.1038/s41467-025-68228-9). A more comprehensive clinical study focused on English-speaking dysarthria patients is currently in preparation at Cambridge.

User Experiences and Challenges

While the initial trials show great promise, some potential challenges can affect user adoption and experience with the Revoice device:

Learning Curve: Users may require time to familiarize themselves with the technology, particularly the phrase activation via nodding.
Ambient Noise: Environments with significant background noise may impact the effectiveness of the sensors.
Maintenance: Users will need guidance on maintaining device cleanliness and ensuring functional longevity.

Despite these challenges, the feedback from clinical trials indicates that the benefits outweigh the potential drawbacks, especially with continued refinement.

Future Plans

The research team aims to enhance Revoice further with:

Multilingual Support: Expanding functionality to accommodate various languages.
Enhanced Emotional Recognition: Improving the ability to capture and interpret emotional states.
Autonomous Operation: Allowing the device to function independently after additional trials, as it is currently just a prototype.

This project is financially supported by the British Council, Haleon, EPSRC, and UKRI. Dr. Luigi Occhipinti emphasizes that Revoice seeks to restore independence and dignity by enabling intuitive communication.

Conclusion

The Revoice collar from the University of Cambridge signifies a groundbreaking step in empowering stroke survivors as they reclaim their ability to communicate. With its non-invasive technology and user-adaptive functions, this AI-driven device not only has the potential to transform the lives of its users but may also extend its benefits to those facing other communication challenges. As clinical trials progress and functionality expands, Revoice is poised to become an invaluable tool in rehabilitation, offering renewed hope and pathways for communication to millions.

Sources

Share this post

Like this post? Share it with your friends!